title: [Tyrosine kinase inhibitors. An approach to pathogenesis-oriented tumor therapy].
authors.affiliation: Abteilung Hämatologie und Onkologie, Universitätsklinik Göttingen.
authors.forename: F
authors.initials: F
authors.lastname: Alves
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000503:physiopathology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000502:physiology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011505:Protein-Tyrosine Kinases
vernacular_title: Tyrosinkinaseinhibitoren. Ein Ansatz zur Pathogeneseorientierten Tumortherapie.